http://www.ctibiopharma.com
CTI BioPharma Corp. Company Intro
Industry
Healthcare
CTI BioPharma Corp. Headquaters
3101 Western Avenue
Seattle,98121
United States
CTI BioPharma Corp. Share price
23 Oct 2020 01:26 GMT
$3.2200
-0.06 (-1.83 %)
CTI BioPharma Corp. Market cap
$246.214 M
WMC RANKING
2020
CTI BioPharma Corp. # 209
BiotechnologyLatest CTI BioPharma Corp. News
22 Oct 2020
Global Renal Disease Treatment Market Analysis by ...
... NephroGenex, Novartis AG, Pfizer, Sanofi, Shire Pharmaceuticals Limited, CTI BioPharma Corp, Merck, Prolong Pharmaceuticals, and VESSL Therapeutics.
22 Oct 2020
Renal Disease Treatment Market: A Fresh Look at Momentum ...
... NephroGenex, Novartis AG, Pfizer, Sanofi, Shire Pharmaceuticals Limited, CTI BioPharma Corp, Merck, Prolong Pharmaceuticals & VESSL Therapeutics.
22 Oct 2020
End-Stage Kidney Disease Treatment Competitive Market ...
CTI BioPharma Corp; F. Hoffmann-La Roche Ltd; Novartis AG; Prolong Pharmaceuticals LLC; VESSL Therapeutics Ltd. The final report will add the analysis of the ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| CTI BioPharma Corp. | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.19 | 100 | 0 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.12 | 0 | 0 | 0 | 91.99 |
| 3SBio Inc. | 96.05 | 0 | 0 | 0 | 0 | 0 | 0 |
| Incyte Corporation | 40.27 | 14.26 | 7.26 | 0 | 0 | 0 | 19.01 |
CTI BioPharma Corp. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| CTI BioPharma Corp. | $3,345 | $43,262 | $-40,020 | $241.791M | 209 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $25.904B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.058B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.953B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.377B | 4 |